Intracellular penetration of macrolides;Penetration intracellulaire des macrolides

Presse Medicale

Volumn 26, Issue SUPPL. 2, 1997, Pages 11-15

  Labro, M T ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; DIRITHROMYCIN; ERYTHROMYCIN; ERYTHROMYCYLAMINE; JOSAMYCIN; MACROLIDE; ROKITAMYCIN; ROXITHROMYCIN; SPIRAMYCIN; ANTIINFECTIVE AGENT;

DRUG ACCUMULATION; DRUG ACTIVITY; HUMAN; INTRACELLULAR TRANSPORT; SHORT SURVEY; ACTIVE TRANSPORT; ANIMAL; CELL MEMBRANE PERMEABILITY; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; CELL MEMBRANE PERMEABILITY; HUMANS; MACROLIDES; TISSUE DISTRIBUTION;

EID: 0030896730     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (23)

1. Fernandes PB. The macrolide revival: Thirty five years after erythromycin. Antimicrob. Newsletter 1987 : 87:25-36.
2. Kirst HA, Sides GD. New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy. Antimicrob. Agents Chemother 1989 : 33:1419-22.
3. Bryskier A, Labro MT. Macrolides: nouvelles perspectives thérapeutiques. Presse Méd 1994 : 23:1762-6.
4. Bryskier A. Newer macrolides and their potential target organisms. Curr Opin Infect Dis 1992 : 5:764-72.
5. Bryskier A, Agouridas C, Chantot JF. New medical targets for macrolides. Exp Opin Invest Drugs 1994 : 3:405-10.
6. Labro MT. Intraphagocytic penetration of macrolide antibiotics. In: Macrolides : biochemistry, pharmacology and clinical uses, Bryskier A, Butzler JP, Neu HC, Tulkens PM eds. Arnette-Blackwell, Paris:379-88.
7. Labro MT. Intracellular bioactivity of macrolides. Clin Microbiol Infect 1996 : 1 (suppl. 1):24-30.
8. Labro MT. Effects of macrolides on host natural defences. In: Macrolides : Biochemistry, pharmacology and clinical uses, Bryskier A, Butzler JP, Neu HC, Tulkens PM eds. Arnette-Blackwell, Paris:389-408.
9. Labro MT. Immunomodulatory action of antibacterial agents. Clin Immunother 1996 ; 6:454-64.
10. Maderazo EG, Kripas CJ, Breaux SP, Woronick CJ, Moore R. Pitfalls in testing drug uptake by leucocytes using radiolabeled drugs and explanation of conflicting results with clindamycin. Chemother (Basel) 1989 ; 35:123-9.
11. Labro MT, Abdelghaffar H, Bryskier A. Characteristics of the cellular accumulation of RU004 by human neutrophil comparison with azithromycin and roxithromycin. 36th Intersci. Conf. Antimicrob Agents Chemother 1996 ; Abstr. F-224.
12. Gladue RP, Snider ME. Intracellular accumulation of azithromycin by cultured human fibroblasts. Antimicrob Agents Chemother 1990 ; 34:1056-60.
13. Meyer AP, Bril-Bazuin C, Mattie H, Van den Broeck PJ. Uptake of azithromycin by human monocytes and enhanced intracellular antibacterial activity against Staphylococcus aureus. Antimicrob Agents Chemother 1993 ; 37:2318-22.
14. Mtairag EM, Abdelghaffar H, Labro MT. Investigation of dirithromycin and erythromycylamine uptake by human neutrophils in vitro. J Antimicrob Chemother 1994 ; 33:523-36.
15. Hand WL, Hand DL. Interactions of dirithromycin with human polymorphonuclear leucocytes. Antimicrob Agents Chemother 1993 ; 37: 2557-62.
16. Carlier MB, Garcia-Luque I, Montenez JP, Tulkens PM, Piret J. Accumulation, release and subcellular localization of azithromycin in phagocytic and non-phagocytic cells in culture. Int J Tissue React 1996 ; XVI: 211-20.
17. Villa P, Sassella D, Corada M, Bartosek I. Toxicity, uptake and subcellular distribution in rat hepatocytes of roxithromycin, a new semisynthetic macrolides and erythromycin base. Antimicrob Agents Chemother 1988 ; 32:1541-6.
18. Mtairag EM, Abdelghaffar H, Douhet C, Labro M.T. Role of extracellular calcium in in vitro uptake and intraphagocytic location of macrolides. Antimicrob Agents Chemother 1995 ; 39:1676-1682.
19. Chastre J, Brun P, Fourtillan JB et al. Pulmonary disposition of roxithromycin (RU 28965) a new macrolide antibiotic. Antimicrob Agents Chemother 1987 ; 31:1312-6.
20. Scaglione F, Demartini G, Dugnani S, Fraschini F. A new model examining intracellular and extracellular activity of amoxicillin, azithromycin and clarithromycin in infected cells. Chemother 1995 ; 39:416-23.
21. Frank MO, Sullivan GW, Carper HT, Mandell GL. In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes. Antimicrob Agents Chemother 1992 ; 36:2584-8.
22. Retsema JA, Bergeron JM, Guaid D, Milisen WB, Girard AE. Preferntial concentration of azithromycin in an infected mouse thigh model. J Antimicrob Chemother 1993 ; 31 (suppl. E):5-16.
23. Fontan PA, Buzzola FR, Spinedi E, Sordelli DO. Haemophilus influenzae type b exoproducts induce chemotaxis and macrolide antibiotic release by human polymorphonuclear leukocytes. Chemother 1996 ; 42:71-77.